A. Kent Christensen, M.D., Ph.D.

Christensen headshot 1981
Image courtesy of the University Record

A. Kent Christensen, M.D., Ph.D., emeritus faculty member in the Department of Cell and Developmental Biology as well as a former chair of the department, died Nov. 17 due to complications following a stroke in Provo, Utah. He was 87. 

Born Dec. 3, 1927, in Washington, D.C., Christensen was raised in Provo. He joined the Marine Corps after high school. He also served a two-and-a-half-year Latter Day Saints mission in France and Belgium beginning in 1949. He graduated from Brigham Young University with a degree in zoology and received a Ph.D. in biology from Harvard University in 1958. He continued postdoctoral studies while teaching and conducting research at Harvard, Stanford University, Temple University and the University of Michigan Medical School. 

Christensen loved science, and sharing his knowledge and expertise. He was also a beloved teacher. Following his retirement in 2012, U-M honored him for achievements in teaching and research with the inauguration of the A. Kent Christensen Collegiate Professorship. 

He loved traveling, learning languages, and reading literary and historical works in their original languages. Over the years he and his wife, Betsy, traveled many places including sabbaticals to Paris and Zurich. 

He will be remembered for his quick wit and sly smile, well-worn stories and familiar sayings, clip-on bowties, passion for research and discovery, deep intellect, unwavering moral code, and love for family and traditions. 

This obituary appeared in the University Record and has been edited for length and clarity. 

More Articles About: emeritus faculty cell and developmental biology Obituary
Featured News & Stories RNA strand in purple on black background
Health Lab
A structural biologist weighs in on the tricky task of determining RNA’s shape
A recent article in Nature details why the quest to determine the shapes of RNA is difficult even for artificial intelligence.
 blue body with red organ lit up
Health Lab
Drug targets identified for pancreatic cancer
U-M researchers have discovered that simultaneously targeting PIKfyve and KRAS-MAPK can eliminate tumors in preclinical human and mouse models.
 Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
This worm can live forever
Figuring out the secrets of planarian worms' immortality could lead to insights about aging for mammals, including people.
 uterus close up grey and teal microscope uterine cells pink and blue background
Health Lab
Mapping the human uterus: diverse cells interact in surprising ways
Michigan Medicine researchers identify new uterine cell types, how they change and how work together through cycles, laying the groundwork for studying challenges like infertility.
 The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
If they don't give up, how can I give up?
Today on The Fundamentals is Dr. Maria Castro, the R.C. Schneider collegiate professor of neurosurgery, and a professor of cell and developmental biology at the University of Michigan Medical School. Her research program aims to develop immunotherapies for primary and metastatic brain cancer, studying basic immune biology mechanisms leading to clinical implementation. She has been inducted into the American Association for the Advancement of Sciences, the Latin American Academy of Sciences, and the American Institute for Medical and Biological Engineering College of Fellows. She has won numerous awards for her contributions to basic science and cancer research and is a diversity ambassador for the Cancer Biology Graduate Training Program. You can learn more about Dr. Castro here, and you can follow her @castro2355_mg, the Rogel Cancer Center @UMRogelCancer, the department of neurosurgery @umichneuro, Michigan Neurscience Institute @UM_MNI and the department of cell and developmental biology @UMCDB on X
 Illustration of a microscope
Health Lab
Helpful enzymes vanish in many patients with antiphospholipid syndrome
Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.